Medicare Part B medical specialty drug prior authorization list is changing in February
We're adding the following medications to the Medicare Plus BlueSM PPO and BCN AdvantageSM Part B specialty prior authorization drug list. These specialty medications are administered in outpatient sites of care, such as a physician's office, an outpatient facility or a member's home.
For dates of service on or after Feb. 3, 2020, the following medications will require authorization:
How to bill
For Medicare Plus Blue and BCN Advantage, we require authorization for these medications for the following sites of care when you bill the medications as a professional service or as an outpatient facility service and you bill electronically through an 837P transaction or on a professional CMS 1500 claim form:
We also require authorization when you bill electronically through an 837I transaction or using a UB04 claim form for a hospital outpatient type of bill 013x.
Important reminder
You must obtain authorization prior to administering these medications. Use the NovoLogix® online tool to quickly submit your authorization requests. It offers real-time status checks and immediate approvals for certain medications. Also note:
If you need to request access to Provider Secured Services, complete the Provider Secured Services Application form and fax it to the number on the form.
List of requirements
For a list of requirements related to drugs covered under the medical benefit, please see the Medical Drug and Step Therapy Prior Authorization List.
The authorization requirements for these drugs will be reflected on the drug list on Jan. 1, 2020.
Posted: October 2019
Lines of business: Blue Cross Blue Shield of Michigan and Blue Care Network